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Abstract 
Background: The effect of gestational diabetes mellitus (GDM) on cardiovascular diseases (CVD) is not assessed 
within the first 10 years postpartum, regardless of subsequent diabetes. The aim of this study was to determine the 
risk of CVD events related to GDM within 7 years of postpartum.
Methods: This nationwide population‑based study of deliveries in 2007 and 2008 with a follow‑up of 7 years was 
based on data from the French medico‑administrative database. Two groups were formed: women with a history of 
GDM and women without GDM or previous diabetes. CVD included angina pectoris, myocardial infarction, stroke, 
heart bypass surgery, coronary angioplasty, carotid endarterectomy and fibrinolysis. Hypertensive disease was 
assessed separately. Determinants studied included age, obesity, subsequent diabetes mellitus and hypertensive 
diseases during pregnancy. Adjusted odds ratios for outcomes were calculated using multiple logistic regressions.
Results: The hospital database recorded 1,518,990 deliveries in 2007 and 2008. Among these, 62,958 women had a 
history of GDM. After adjusting for age, DM, obesity and hypertensive disorders in pregnancy, GDM was significantly 
associated with a higher risk of CVD (adjusted Odds Ratio aOR = 1.25 [1.09–1.43]). Considering each variable in a 
separate model, GDM was associated with angina pectoris (aOR = 1.68 [1.29–2.20]), myocardial infarction (aOR = 1.92 
[1.36–2.71]) and hypertension (aOR = 2.72 [2.58–2.88]) but not with stroke.
Conclusions: A history of GDM was identified as a risk factor of CVD, especially coronary vascular diseases, within the 
7 years postpartum. A lifestyle changes from postpartum onwards can be recommended and supported.
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Background
Identifying early markers of CVD is a major challenge 
since CVD is responsible for 30  % of female deaths 
according to the WHO [1].
In France, the prevalence of the Gestational Diabetes 
Mellitus (GDM) ranges from 2 to 6 % [2]. GDM is defined 
as a high blood glucose level which appears or is diag-
nosed for the first time during pregnancy. Most women 
return to normoglycemia, but a substantial proportion 
of them experiences the emergence of type 2 diabetes 
(T2DM). The proportion reaches around 50  % within 
10  years [3] and around 70  % 28  years postpartum [4, 
5]. This is why GDM has been identified as a category of 
Diabetes Mellitus (DM) by the American Diabetes Asso-
ciation [6]. The principal complications of T2DM are 
cardiovascular diseases [7] (CVD), the risk of which is 
potentiated by obesity, oral contraceptives and hyperten-
sive disorders of pregnancy [5, 8–13]. Indeed, the risk of 
coronary artery disease is four to six times higher in dia-
betic women [5].
Some studies have shown that a history of GDM 
increases the risk of CVD [13–15], and that the increase 
was mainly related to the onset of T2DM. One study 
found that GDM was associated with an increased risk of 
CVD before the onset of T2DM in women who had first-
degree relatives with T2DM [16]. Evidence of the GDM 
effect regardless of T2DM status remains inconclusive 
[17, 18]. However, some studies reported that women 
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with a history of GDM showed subclinical atherosclero-
sis [19], increased markers of endothelial dysfunction [20, 
21], an increased risk of cardiac dysfunction [3, 7, 22, 23] 
and a significantly higher prevalence of metabolic syn-
drome very soon after pregnancy [24, 25].
These data suggest that some young women with a his-
tory of GDM may be prone to the development of cardio-
metabolic disorders [21] and early increases in CVD risk. 
These young at-risk women for CVD may benefit from 
preventive strategies.
For 20  years, hospital data have been used for medi-
cal research purposes and the quality of the French hos-
pital database has been confirmed in recent studies. It 
provides a huge amount of epidemiological information 
concerning hospitalized patients in France [26–29], and 
can be used to create large enough cohorts to detect rare 
events.
The aim of the present investigation was to determine, 
from this hospital database, whether women with GDM 




The principle of this nationwide population-based retro-
spective study was to examine hospital data in France for 
deliveries in 2007 and 2008, and CVD until 2013.
In the medico-administrative database, deliveries were 
identified from the codes Z37 which were considered 
the most reliable and extensive [30]. Two groups were 
formed: women who experienced GDM during preg-
nancy and women without GDM during pregnancy in 
2007 or 2008 or in subsequent pregnancies until 2013. 
Women with previously diagnosed diabetes mellitus 
(DM) in 2007 or 2008 were excluded. If there was more 
than one delivery in the 2 years, hospital stays were stud-
ied one by one and taken into account if a period of at 
least 150  days had elapsed between two deliveries. If 
there was at least one case of GDM during one of the 
pregnancies, women were included in the GDM group. 
Otherwise, women were included in the group without 
GDM.
Outcomes
The outcome of interest was CVD, which included angina 
pectoris (I20), myocardial infarction (I21-I22-I23) [28–
31] but also ischemic stroke (I63–I64), transient cerebral 
ischemic attacks (TIA) and vascular syndromes of brain 
in cerebrovascular diseases (G46–G45 except G45.4) 
[32] coded as the main or associated diagnosis accord-
ing to International Classification of Diseases (ICD-
10) codes, and coronary artery bypass graft, coronary 
angioplasty, carotid endarterectomy (surgical removal 
of atheromatous plaque from an artery) and fibrinoly-
sis (defined by the dissolution of clot with fibrinolytic 
agents), coded according to the French Common Classi-
fication of Procedures. When analysing ischemic stroke 
separately, we only considered ischemic strokes from 
cardio-embolism, atheroma or dissection of large arteries 
as carotid, vertebral or basilar arteries, microangiopathy 
so-called lacunar stroke induced by blood hypertension, 
diabetes or tobacco abuse, and undetermined ischemic 
(I63–I64). These cardiovascular events and therapeutic 
measures, coded during hospitalizations from delivery to 
2013, were collected for each woman.
Variables
The following explanatory variables were considered: 
maternal age, which was defined as the age of the mother 
at the time of birth (<20, 20–29, 30–39 and ≥40 years), 
hypertensive disorders of pregnancy (O10–O16), obe-
sity ≥30 kg/m2 (E66) and subsequent diabetes (E10–E14) 
from 2007 to 2013. These last three variables were taken 
into account when the main or associated ICD-10 codes 
were found in the different hospitalizations of the same 
patient from the first delivery to the onset of cardiovas-
cular event. Women aged under 12 and over 51  years 
were excluded from this study as the records were prob-
ably erroneous and including them would have biased the 
mean age at the first cardiovascular event.
Statistical analysis
Individual characteristics are presented as proportions. 
Comparisons were made using a Chi squared test. The 
reference group included women without GDM in 2007, 
2008 or until 2013. Multiple logistic regression analyses 
with backward selection were used to assess the associa-
tion between a history of GDM and CVD.
The number of subjects required was not calculated as 
it was a population-based study.
SAS9.3 was used for the descriptive and multivariate 
analyses.
This study was approved by the National Commit-
tee for data protection (registration number 1576793). 
Written consent was not needed for this study. The data 
from the PMSI database was transmitted by the national 
agency for the management of hospitalization data 
(ATIH number 2015-111111-47-33).
Results
The hospital database recorded 1,518,990 deliveries in 
2007 and 2008 in France. Among these, 62,958 women 
had a history of GDM (prevalence of 4.14  %) and 3603 
had previous DM.
The comparison of women’s characteristics is pre-
sented in Table  1. Women who had GDM were older 
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(31.8 vs 29.4) and were more likely to have obesity (12.90 
vs 3.87 %), subsequent DM (2.01 vs 0.12 %) and hyperten-
sive disorders of pregnancy (7.68 vs 2.89 %). There were 
229 cardiovascular events (angina pectoris, myocardial 
infarction, ischemic stroke, TIA and vascular syndromes 
of brain in cerebrovascular diseases) in the 62,958 
women with a history of GDM and 3400 CVD events 
in the 1,452,429 women without GDM or previous DM. 
Angina pectoris (0.10 %), myocardial infarction (0.04 %) 
and ischemic stroke including TIA (0.22 %) were signifi-
cantly more frequent in the GDM group. The frequency 
of hypertension was also significantly higher among 
women with a history of GDM. On average, women with 
a history of GDM were 39.2 years old [Standard Devia-
tion (SD) 6.6] at the first episode of angina pectoris, 
40.6 years old (SD 6.0) at the first myocardial infarction, 
and 36.3 years old (SD 5.6) at the first ischemic stroke or 
TIA. The average time between delivery and the first car-
diovascular event was 3.4 years (SD 1.8) for angina pec-
toris, 3.8 years (SD 1.8) for myocardial infarction and 3.2 
(SD 1.9) for ischemic stroke and TIA.
The number of cases of angina pectoris, myocardial 
infarction or ischemic stroke and TIA according to time 
after delivery is presented in Fig. 1 for women who expe-
rienced GDM.
The results of the logistic regression analysis adjusted 
for age showed that GDM was significantly associ-
ated with a higher risk of CVD (Table  2). Considering 
each variable in a separate model, GDM significantly 
increased the risk of angina pectoris (adjusted Odds 
Ratio aOR  =  2.05, 95  % Confidence Interval [1.58–
2.67]), myocardial infarction (aOR  =  2.07 [1.47–2.90]), 
and hypertensive diseases (aOR  =  2.92 [2.77-3.08]) but 
not the risk of stroke (defined by ischemic strokes, TIA 
and vascular syndromes of the brain). When analyzing 
only ischemic strokes, GDM significantly increased the 
risk of these diseases (aOR =  1.28 [1.01–1.62]). Table  3 
presents the results of the logistic regression analy-
sis adjusted not only for age but also for obesity, subse-
quent diabetes and hypertensive disorders of pregnancy. 
CVD overall (aOR = 1.25 [1.09–1.43]) as well as angina 
pectoris (aOR  =  1.68 [1.29–2.20]), myocardial infarc-
tion (aOR = 1.92 [1.36–2.71]) and hypertensive diseases 
(aOR  =  2.72 [2.58–2.88]) were still significantly associ-
ated with GDM.
Discussion
The novelty and interest of the study lies in the fact that 
it shows the association between a history of GDM and 
cardiovascular events during the 7  years after delivery, 
Table 1 Characteristics and adverse outcomes in women with history of GDM
GDM gestational diabetes mellitus
a Coronary artery bypass graft, coronary angioplasty, carotid endarterectomy and fibrinolysis
GDM 2007–2008 No GDM 2007–2008 p value
(n = 62,958) (n = 1,452,429)
Size (%) Size (%)
Age <0.0001
 <20 520 0.83 42,313 2.91
 20–29 21,471 34.10 706,688 48.66
 30–39 35,922 57.06 656,693 45.21
 ≥40 5045 8.01 46,735 3.22
Obesity 8122 12.90 56,142 3.87 <0.0001
Subsequent diabetes 1266 2.01 1674 0.12 <0.0001
Hypertensive disorders during pregnancy 4834 7.68 42,012 2.89 <0.0001
Angina pectoris 64 0.10 570 0.04 <0.0001
Myocardial infarction
 Acute myocardial infarction 26 0.04 257 0.02 <0.0001
 Repeated myocardial infarction 0 0 2 0 1
 Complications of acute myocardial infarction 0 0 11 0 1
Stroke
 Ischemic stroke 71 0.11 1181 0.09 <0.05
 Vascular syndromes of brain in cerebrovascular diseases 9 0.01 160 0.01 0.34
 Transient cerebral ischemic attacks 59 0.09 1219 0.08 0.06
Hypertensives diseases 1566 2.49 10,586 0.73 <.0001
Therapeutic measuresa 32 0.05 236 0.02 <.0001
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especially myocardial infarction and angina pectoris, 
independently of the occurrence of DM.
We acknowledge that the present study has several 
limitations. First, the study focused only on women who 
had been hospitalized between 2007 and 2013 and for 
CVD, including angina pectoris, which does not neces-
sarily require hospitalization. Second, we could not take 
into account the women’s medical history before 2007, as 
French hospital data were unable to identify in a reliable 
manner events prior to 2007.
The strength of this study lies in the ability of the 
French hospital database to capture important maternal 
information for all deliveries in France. In previous stud-
ies, Quantin et al. compared such information from vari-
ous sources and showed that it was possible to identify 
deliveries in mainland France with a difference of 0.3 % 
compared with the civil registry, which records all births 
in our country [33]. In a pilot study in 2012 based on 20 
cases of GDM from 300 medical records [34], Pierron 
et al. also assessed the ability of French hospital data to 
identify GDM and found a positive predictive value of 
88.9 % [74.3–100].
French hospital data allowed the satisfactory, though 
not optimal, identification of women who had GDM. Our 
results showed a prevalence of 4.14 %, which is in keep-
ing with the prevalence between 2 and 6 % in France and 
Europe [2].
Our results regarding the hypertensive risk associ-
ated with a history of GDM were similar to those of 
previous studies [16–35]. A retrospective study carried 
out between 1998 and 2007 in Massachusetts found an 

















Fig. 1 Number of cases by interval time after delivery for women with a history of GDM. AP angina pectoris, MI myocardial infarction, stroke 
ischemic stroke, TIA and vascular syndromes of brain in cerebrovascular diseases
Table 2 Association between  gestational diabetes mellitus and  cardiovascular diseases adjusted for  age—Multivariate 
logistic regressions
CVD cardiovascular diseases (including angina pectoris, myocardial infarction, stroke, heart bypass, coronary angioplasty, carotid and endarterectomy and fibrinolysis 
intervention), aOR adjusted odds ratio, CI confidence interval




Model 4: ischemic 
stroke and TIA




aOR [95 % CI] aOR [95 % CI] aOR [95 % CI] aOR [95 % CI] aOR [95 % CI]
Gestational diabetes 
mellitus  
age (ref = 21–29)
1.39 [1.21–1.59] 2.05 [1.58–2.67] 2.07 [1.47–2.90] – 1.28 [1.01–1.62] 2.92 [2.77–3.08]
<20 0.48 [0.35–0.67] 0.29 [0.09–0.91] 0.71 [0.22–2.26] 0.50 [0.35–0.72] 0.73 [0.47–1.13] 0.44 [0.36–0.54]
30–39 1.54 [1.43–1.65] 2.06 [1.72–2.47] 3.32 [2.55–4.32] 1.35 [1.25–1.47] 1.47 [1.31–1.65] 1.95 [1.87–2.03]
≥40 2.99 [2.63–3.40] 7.10 [5.53–9.12] 9.55 [6.69–13.64] 1.99 [1.68–2.37] 2.23 [1.76–2.83] 4.63 [4.34–4.93]
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a history of GDM after adjustment for several CVD 
risk factors (HR 1.75 [1.28–2.37]) [35]. Another study 
reported an 88 % increased risk of hypertension in such 
women after adjusting for age, menopausal status, and 
race/ethnicity (OR 1.88 [1.34–2.64]) [16].
In agreement with our results, a scoping review [17] 
which included studies by Carr et  al. [16.] and Freibert 
et al. [36], concluded that the association between history 
of GDM and stroke was inconclusive.
As regards cardiovascular diseases, most studies 
showed an overall increase in CVD risk beyond 10 years 
postpartum [15, 16, 37]. In a case–control study, the 
adjusted odds ratio for the association of GDM with 
cardiovascular disease was 1.51 [1.07–2.14] for a mean 
follow-up of 9.1 years. [37]. In a population-based cohort 
study, Shah et  al. found that CVD risk increased in the 
11.5 years following the index pregnancy (HR 1.71 [1.08–
2.69]) but the association was attenuated when adjusted 
for subsequent diabetes (HR 1.13 [0.67–1.89]) [15]. Only 
one study concluded that GDM increased self-reported 
CVD in young women (45.5 years on average) who had 
first-degree relatives with T2DM and this independently 
of T2DM in the women themselves (aOR = 1.85 [1.21–
2.82]) [16].
To our knowledge, no study has shown that women 
with a history of GDM had a higher risk of being hos-
pitalized for CVD events during the 7  years follow-
ing delivery, regardless of subsequent DM, obesity and 
hypertensive disorders of pregnancy. Our results showed 
that the early increase in CVD risk cannot be exclusively 
attributable to the subsequent development of diabetes. 
Although our study included only hospitalized women, 
who can be considered less healthy, these findings are 
consistent with previous studies that estimated car-
diovascular risk in the short term after pregnancy [18, 
19, 22]. One study showed an increased risk of cardiac 
dysfunction in women with GDM at least 1  year after 
delivery [22]. Similarly, according to Gunderson et al., a 
history of GDM can be considered a risk factor for ath-
erosclerosis before the onset of diabetes or metabolic 
syndrome [18].
The prevalence of CVD in women with GDM remains 
low up to 7  years after delivery. Only 90 of the 62,958 
women with a history of GDM experienced coronary 
vascular diseases. This small number of individuals can-
not justify systematic screening for coronary heart dis-
ease or the inclusion of GDM history in the risk profile.
However, the increased risk of CVD does lead us to 
recommend the control of other risk factors and life-
style changes from postpartum onwards. As pregnancy 
is a period during which women are particularly aware 
of own health behavior and that of their children, it 
offers a window of opportunity for clinicians to act and 
propose lifestyle changes, for example. A partnership 
between clinicians and women with a history of GDM 
should be encouraged. This period of safe behavior may 
be extended by appropriate support programs which take 
into account the living conditions of working women 
with young children [38, 39]. The central idea is to engage 
women in a health education approach to promote 
healthy ageing.
In conclusion, our study showed for the first time that 
GDM is an independent factor risk of CVD in the 7 years 
following delivery. It suggests that effective management 
of risk factors should be implemented in these women 
from postpartum onwards.
Table 3 Association between gestational diabetes mellitus and cardiovascular diseases adjusted for age, obesity, subse-
quent diabetes and hypertensive diseases during pregnancy—Multivariate logistic regressions
CVD cardiovascular diseases (including angina pectoris, myocardial infarction, stroke, heart bypass, coronary angioplasty, carotid and endarterectomy and fibrinolysis 
intervention), aOR adjusted odds ratio, CI confidence interval




Model 4: ischemic 
stroke and TIA




aOR [95 % CI] aOR [95 % CI] aOR [95 % CI] aOR [95 % CI] aOR [95 % CI]
Gestational diabetes 
mellitus  
age (ref = 21–29)
1.25 [1.09–1.43] 1.68 [1.29–2.20] 1.92 [1.36–2.71] – – 2.72 [2.58–2.88]
<20 0.49 [0.35–0.68] 0.29 [0.09–0.92] 0.71 [0.22–2.25] 0.50 [0.35–0.72] 0.73 [0.47–1.14] 0.44 [0.35–0.54]
30–39 1.54 [1.44–1.66] 2.07 [1.73–2.48] 3.32 [2.55–4.32] 1.36 [1.25–1.47] 1.48 [1.32–1.66] 1.95 [1.87–2.03]
≥40 2.93 [2.57–3.34] 6.98 [5.43–8.96] 9.52 [6.67–13.60] 1.96 [1.65–2.33] 2.23 [1.76–2.83] 4.63 [4.34–4.93]
Obesity 1.53 [1.34–1.75] 2.18 [1.67–2.85] – 1.34 [1.13–1.58] 1.34 [1.06–1.69] –




1.78 [1.55–2.05] 1.87 [1.39–2.55] – 1.63 [1.37–1.95] 1.72 [1.35–2.20] –
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